ESCMID Study Group for Immunocompromised Hosts - ESGICH
News & Activities
ESGICH Executive Committee election results
The ESGICH Executive Committee elections have concluded and the following members have been elected for the term of 2023-2025:
- Maddalena Giannella, Italy
- Monica Slavin, Australia
- Elisa Cordero Matia, Spain
- Nicolas Mueller, Switzerland
- Michael G Ison, USA
The new Executive Committee will take office during the ESGICH meeting at ECCMID this year.
We thank all previous Executive Committee members for their excellent work over the last years and are looking forward to continuing this work.
You can find the full election report here
2022 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2022 as well as what they plan for the future.
SSAI & ICHS Joint Meeting 2022, Basel, 8-11 September 2022
ESGICH members are invited you to the Annual Congress of the Swiss Society for Allergology and Immunology (SSAI) and to the 22nd Symposium of the International Immunocompromised Host Society (ICHS) that will take place as a joint conference in September 8 -11, 2022 at the Congress Center in Basel, Switzerland.
Together with the members of the Local, the National and the International Scientific Board and the Organizing Committee, they have developed an appealing program to cover the state-of-the art of clinical practice, and to provide a unique forum of discussion which integrates the most recent international developments in clinical, translational, and basic research in academic, clinical and pharmaceutical organisations.
Cheering the motto of «Infection and immunity - Are you competent?» they are looking forward to welcoming you and your colleagues, peers, friends and professional collaborators to Basel in September 2022 and to an exciting Congress.
See the congress website here
2021 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. Be sure to check out the report to see what the Study Group was able to accomplish in 2021 as well as what they plan for the future.
ESGICH Executive Committee election results
The ESGICH Executive Committee elections have concluded and the following members have been elected for the term of 2021-2023:
- Jose Maria Aguado Garcia, Spain (Science Officer)
- Monica Slavin, Australia (Secretary)
- Paolo Grossi, Italy (Chair)
- Carlos Cervera, Canada (Education Officer)
- Christian Van Delden, Switzerland (Treasurer)
The new Executive Committee will take office during the ESGICH meeting at ECCMID this year.
We thank all previous Executive Committee members for their excellent work over the last years and are looking forward to continuing this work.
You can find the full election report here
2020 Annual Report Published
The Annual Report showcasing the achievements of the previous year is now available to view. 2020 was a challenging year due to COVID-19, but check out the report to see what the Study Group was able to accomplish or plan for the future.
ESCMID Postgraduate Education Course
Safety of Targeted and Biological Therapies: an Infectious Diseases Perspective
Organised by ESGICH
Madrid, Spain - 12-13 March 2021
Throughout this educational course, the attendees willlearn how to manage and prevent the infectious complicationsassociated with the use of new targeted and biologicaltherapies, with particular focus on the clinical implementationof risk-minimization strategies. The programme will consist of a 2-day conference with formal lectures illustrated with clinical cases and meet-the-expert sessions.
ESCMID Postgraduate Education Course
Infectious Complications in Haematology Patients, including Stem Cell Transplant Recipients
Co-organised by ESGICH, ESCMID and the International Society Immunocompromised Host (ICHS)
Genoa, Italy, 20 – 21 June 2019
Diagnosis and management of infections in haematology is a difficult exercise. In addition to the old predisposing conditions (neutropenia and mucositis), the increasing use of targeted therapies is posing new challenges. Moreover, colonization or past infection with multidrug resistant (MDR) organisms is one of the factors to take into consideration when deciding whether or not haematological interventions are safe and feasible, since subsequent infections can be fatal. Pathogens considered rare in certain settings enter now the differential diagnosis because of the new therapeutic approaches and patients’ mobility. Additionally, antimicrobial stewardship in this population is particularly important to optimize the treatment outcomes, prevent the spread of MDR bacteria and preserve antibiotic activity for future infections. In all these situations, close collaboration between treating haematologists and infectious diseases and microbiology specialists is fundamental. This course offers a comprehensive update on all these issues provided by a multidisciplinary team.
Course material in the ESCMID eLibrary
New Executive Committee takes office
April 13, 2019
ESGICH has a new executive committee composed of:
- Chairperson: Prof. Paolo Antonio Grossi, Italy
- Secretary: Dr Monica Slavin, Australia
- Treasurer: Prof. Christian Van Delden, Switzerland
- Science Officer: Prof. Jose Maria Aguado Garcia, Spain
- Education Officer: Dr Carlos Cervera, Canada
Nicolas Mueller and Julien Coussement as members of the election committee invited the membership to nominate candidates and vote. The results of the elections are the following:
- Number of members with voting right: 140
- Number of voters: 53 (37.9%)
Candidates:
- José M. Aguado, Spain 34, elected
- Monica Slavin Peter, Australia 26, elected
- Paolo Grossi, Italy 21, elected
- Christian Van Delden, Switzerland 18, elected
- Carlos Cervera, Canada 30.19% 16, elected
- Edson Abdala, Brazil 20.75% 11, non-elected
- Yasemin Cag, Turkey 16.98% 9, non-elected
- Bernd Salzberger, Germany 7, non-elected
- No preference 1
The new executive committee is elected for two years.
CMI Website
eAcademy
EUCAST
